HEPA · Forms 3, 4, 5

Insider trades at Hepion Pharmaceuticals, Inc.

1 insider bought $10K of Hepion Pharmaceuticals, Inc. stock on the open market in the last 30 days.

Every Form 3, 4 and 5 filed for Hepion Pharmaceuticals, Inc. (HEPA) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Insider trades in the last 90 days

DateInsiderRoleTransactionSharesPriceValueFiling
Danina FisherDirectorBuy200,000$0.05$10KForm 4
KI Holdings, Ltd.10% ownerBecame an insider (Form 3)Form 3
Vincent S LoPrioreExecutive ChairmanOptions or other derivativesForm 4
Michael J. PurcellDirectorOptions or other derivativesForm 4
Gary S. StetzInterim CEOOptions or other derivativesForm 4
Vincent S LoPrioreExecutive ChairmanOptions or other derivativesForm 4
Chase LoPrioreVP, Corp. Dev.Options or other derivativesForm 4
Danina FisherDirectorOptions or other derivativesForm 4
James Gordon LiddyDirectorOptions or other derivativesForm 4
Sireesh AppajosyulaChief Operating OfficerOptions or other derivativesForm 4
Gary S. Stetz IIDirectorOptions or other derivativesForm 4
James Gordon LiddyDirectorBecame an insider (Form 3)Form 3
Black Global 5 LLC10% ownerBecame an insider (Form 3)Form 3
Gary S. Stetz IIDirectorBuy500,000$0.05$25KForm 4
Gary S. StetzInterim CEOBuy2,000,000$0.05$100KForm 4
Michael J. PurcellDirectorBuy2,000,000$0.05$100KForm 4
Sireesh AppajosyulaChief Operating OfficerBuy2,000,000$0.05$100KForm 4
Vincent S LoPrioreExecutive ChairmanBuy8,000,000$0.05$400KForm 4
Vincent S LoPrioreExecutive ChairmanBuy2,000,000$0.05$100KForm 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.